SEC Form 4 · accession 0001193125-26-379524
MiNK Therapeutics, Inc. · INKT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Bradley Holcomb
Director
Period of report
Sep 1, 2026
Accepted (ET)
Sep 2, 2026 · 10:21 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001840229
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 1, 2026 | A | 1,233 | $10.95 | A | 4,691 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.